Internet-based Multidisciplinary Rehabilitation for Longterm COVID-19 Syndrome (COVID-19)

July 12, 2021 updated by: Indre Ljungar, Danderyd Hospital
Internet-based multidisciplinary interventions will be offered to participants suffering from longterm COVID-19 syndrome. Data will be collected by internet platform at Karolinska Institutet (BASS) before, after rehabilitation and at follow-up after 6 months. Both self-scored questionnaires and physical tests performed at home will be collected to understand the symptomatology, functioning and activity level. Rehabilitation during 8 weeks period will be given in groups as face-to-group, pre-recorded film sessions and by individual approach, the participants will use ExorLive app for physical activity.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This randomised study aimed to understand if multidisciplinary internet-based interventions performed in group and individually are applicable for participants suffering from longterm COVID-19 syndrome. Data will be collected by internet platform at Karolinska Institutet (BASS) before, after rehabilitation and at follow-up after 6 months. Both self-scored questionnaires and physical tests performed at home will be collected to understand the symptomatology, functioning and activity level. Rehabilitation during 8 weeks period will be given in groups as face-to-group, pre-recorded film sessions and by individual approach, the participants will use ExorLive app for physical activity.

The participants will be randomised for treatment and waiting lists using a website random.org. Waiting list will be offered rehabilitation interventions after at least 8 weeks period of waiting to exclude a spontaneous improvement or worsening of symptoms. To understand the impact of rehabilitation on work capacity and employment/economic supply, the data from Social Insurance databas will be obtained 2021 year before and upp to 2 years after the intervention. To understand the impact of rehabilitation on sickness-leave, the data from National Insurance Agency will be obtained for 2021 and 2022.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Indre Bileviciute-Ljungar, Associated professor
  • Phone Number: +46858703158
  • Email: indre.ljungar@ki.se

Study Contact Backup

Study Locations

      • Stockholm, Sweden, 112 19
        • Recruiting
        • St Goran Hospital
        • Contact:
          • Indre Bileviciute-Ljungar, Associated professor
          • Phone Number: +46858703158
          • Email: indre.ljungar@ki.se
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • confirmed COVID-19 infection
  • post-infection symptoms lasting longer than 3-6 months
  • clinically stable persons regarding symtoms or other co-morbidities
  • ability to participate in internet-based rehabilitation in group in Swedish.

Exclusion Criteria:

  • uncertainty regarding covid-19 infection or co-morbidities started or exacerbated during the same time
  • alcohol and drug abuse
  • untreated psychiatric and somatic co-morbidities
  • undergoing medical or psychotherapeutic treatment or rehabilitation which can interact with rehabilitation outcomes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rehabilitation group
Rehabilitation group will be provided multidisciplinary interventions online and individually by ExorLive app. The screening with self-scored questionnaires and physical tests will be performed before and after 8 weeks rehabilitation.
Body therapies to improve breathing, normalise dysfunction in the autonomic nervous system, relaxation, mindfulness, in some part Acceptance and Commitment Therapy given preferably through body therapies.
Other Names:
  • Individually performed physical activity recorded into ExorLie app.
No Intervention: Waiting list controls
Passive waiting list or control group, which will be offered to participate in rehabilitation after at least 8 weeks of waiting time. The group will fulfil screening twice, following the time schedule of intervention group. When invited to rehabilitation a new screening will be asked to be completed if the waiting time after the last screening will be longer than 2 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in health-related quality of life measured by Short Form-36
Time Frame: Investigators expect changes at 6 months follow-up after rehabilitation
Important sub scales: vitality, general health, physical functioning, pain. Scale varies between 0 and 100 (highest)
Investigators expect changes at 6 months follow-up after rehabilitation
Changes in heart rate variability during physical tests
Time Frame: Investigators expect normalisation at 6 months follow-up
Heart rate variability measured by puls oximeter during 2 physical tests
Investigators expect normalisation at 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall changed scores in validated questionnaires for fatigue, breathing, pain and sleep disorders
Time Frame: Investigators expect changes already at 6 months follow-up
Validated self-scored questionnaires such as Multidimentional Fatigue Inventory - for fatigue (values 0-20), Clinical COPD Questionnaire - for breathing (0-50), Chronic Visual Analogue Scale - for pain (0-100), Insomnia Severity Scale - for sleep (0-21) and other questionnaires.
Investigators expect changes already at 6 months follow-up
Changed functioning and activity
Time Frame: Investigators expect normalisation at 6 months follow-up
Functioning and activity will be evaluated by self-scored questionnaires and a new questionnaire Functional compass for COVID-19 based on ICF (International Classification of Functioning and Disability)
Investigators expect normalisation at 6 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2021

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

May 7, 2021

First Submitted That Met QC Criteria

July 12, 2021

First Posted (Actual)

July 14, 2021

Study Record Updates

Last Update Posted (Actual)

July 14, 2021

Last Update Submitted That Met QC Criteria

July 12, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Long COVID-19

Clinical Trials on Multidisciplinary Rehabilitation

Subscribe